Ischemia-reperfusion Exercise Study

Sponsor

University of Copenhagen (Other)

Overall Status

Completed

CT.gov ID

NCT04872426

Collaborator

(none)

Enrollment

Location

Arms

16.1

Actual Duration (Months)

0.6

Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The study investigates the relationship between activation of AMP-activated protein kinase (AMPK) in human skeletal muscle and the subsequent improvement in muscle insulin sensitivity for the stimulation of glucose uptake.

This will be investigated in young healthy lean male subjects.

Condition or Disease	Intervention/Treatment	Phase
Insulin Sensitivity	Other: Exercise, insulin infusion	N/A

Detailed Description

This study aims to demonstrate the association between AMPK activation and increased insulin sensitivity in human skeletal muscle. The investigators intend to examine insulin sensitivity after various levels of AMPK activation in skeletal muscle that includes exercise at different intensities as well as exercise combined with leg blood flow restriction (ischemia). The hypothesis is that exercise combined with ischemia will result in an increased activation of AMPK compared to exercise alone, and therefore it is expected that exercise combined with ischemia will result in the greatest improvement in muscle insulin sensitivity.

Methods:

The main experiment consists of 3 experimental days (A, B and C), separated by a minimum of 14 days and carried out in a randomised order. On all the study days, the participants will arrive in the laboratory after an overnight fast. Catheters will be placed in both femoral veins and in one femoral artery. A muscle biopsy will be obtained from vastus lateralis of one leg (resting leg). Experiment A consists of one-legged muscle work for 1 hour at 70% of the leg maximum aerobic work capacity with the other leg serving as a resting control. In experiment B, the same work are performed, but with periodic at the same constricting the blood supply to the working leg (25 seconds every 2 min). Experiment C consists of one-legged muscle work for 1 hour at 70% and 95% of the leg maximum aerobic work capacity (alternately every 5 min). Immediately after each type of exercise a biopsy will be obtained from the exercising leg and the participants will rest in the fasted state for 3 hours before a third set of muscle biopsies (from both legs) will be obtained. Subsequently, insulin sensitivity will be evaluated in the participants during a 2-hour physiological hyperinsulinemic euglycemic clamp. By the end of the clamp, a final set of biopsies (both legs) will be obtained. Throughout the study day sampling of artery and venous blood/plasma samples allows for the estimation of substrate extraction by the two legs. Further, measures of artery blood flow by Ultrasound Doppler technique allow for the final calculation of substrate uptake/release across the two legs before exercise, during exercise and in recovery from exercise. Importantly, the ability for insulin to stimulate these processes can be evaluated in both a rested and in a prior exercised leg.

Study Design

Study Type:

Interventional

Actual Enrollment :

10 participants

Allocation:

Randomized

Intervention Model:

Crossover Assignment

Masking:

None (Open Label)

Primary Purpose:

Basic Science

Official Title:

Effect of Ischemia on the Insulin-sensitizing Effect of Exercise

Actual Study Start Date :

Aug 31, 2018

Actual Primary Completion Date :

Jan 3, 2020

Actual Study Completion Date :

Jan 3, 2020

Arms and Interventions

Arm	Intervention/Treatment
Experimental: Low intensity exercise 70% of maximal leg work load capacity	Other: Exercise, insulin infusion Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise
Experimental: High intensity exercise 70% and 95% of maximal work load capacity (alternately every 5 min)	Other: Exercise, insulin infusion Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise
Experimental: Low intensity exercise + intermittent ischemia-reperfusion 70% of maximal leg work load capacity with intermittent ischemia (25 seconds every 2 min)	Other: Exercise, insulin infusion Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise

Arm

Intervention/Treatment

Experimental: Low intensity exercise

70% of maximal leg work load capacity

Other: Exercise, insulin infusion

Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise

Experimental: High intensity exercise

70% and 95% of maximal work load capacity (alternately every 5 min)

Other: Exercise, insulin infusion

Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise

Experimental: Low intensity exercise + intermittent ischemia-reperfusion

70% of maximal leg work load capacity with intermittent ischemia (25 seconds every 2 min)

Other: Exercise, insulin infusion

Acute one-legged exercise, Insulin infusion 3 hours after one-legged exercise

Outcome Measures

Primary Outcome Measures

Muscle glucose uptake during exercise and enhanced insulin sensitivity in recovery from exercise. [Through study completion, an average of 1 year.]
Leg glucose uptake is calculated by the arterial-venous difference i blood glucose concentration multiplied with leg blood flow. Sampling of artery and venous blood samples for blood glucose measurements. Measures of artery blood flow by Ultrasound Doppler technique allows a final calculation of glucose uptake across the legs before exercise, during exercise, in recovery from exercise and with insulin stimulation.

Secondary Outcome Measures

AMPK activity in muscle biopsies [5 years]
The obtained muscle samples will be subjected to protein kinase activity measurements.
Posttranslational modification of proteins in muscle biopsies [5 years]
The obtained muscle samples will be subjected to standard western blotting for the evaluation of posttranslational modifications of various proteins involved in glucose metabolism.

Eligibility Criteria

Criteria

Ages Eligible for Study:

25 Years to 35 Years

Sexes Eligible for Study:

Male

Accepts Healthy Volunteers:

Yes

Inclusion Criteria:

normal weight (BMI: below or equal to 27)
physical active on a regular basis
cardiorespiratory fitness between 40-60 ml/kg/min
no history or sign of type 2 diabetes, hypertension, insulin resistance or dyslipidemia